Literature DB >> 33036721

MicroRNAs and Long Noncoding RNAs in Coronary Artery Disease: New and Potential Therapeutic Targets.

Lukasz Zareba1, Alex Fitas1, Marta Wolska1, Eva Junger1, Ceren Eyileten1, Zofia Wicik2, Salvatore De Rosa3, Jolanta M Siller-Matula4, Marek Postula5.   

Abstract

Noncoding RNAs (ncRNAs), including long noncoding RNAs and microRNAs, play an important role in coronary artery disease onset and progression. The ability of ncRNAs to simultaneously regulate many target genes allows them to modulate various key processes involved in atherosclerosis, including lipid metabolism, smooth muscle cell proliferation, autophagy, and foam cell formation. This review focuses on the therapeutic potential of the most important ncRNAs in coronary artery disease. Moreover, various other promising microRNAs and long noncoding RNAs that attract substantial scientific interest as potential therapeutic targets in coronary artery disease and merit further investigation are presented.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Long noncoding RNA; lncRNAs; miR-155; miR-33; miR-92a; miRNAs; microRNA

Mesh:

Substances:

Year:  2020        PMID: 33036721     DOI: 10.1016/j.ccl.2020.07.005

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  7 in total

Review 1.  The role of non-coding RNAs in neuroinflammatory process in multiple sclerosis.

Authors:  Anna Nowak; Zofia Wicik; Marta Wolska; Andleeb Shahzadi; Piotr Szwed; Joanna Jarosz-Popek; Jeffrey Palatini; Marek Postula; Anna Czlonkowska; Dagmara Mirowska-Guzel; Ceren Eyileten
Journal:  Mol Neurobiol       Date:  2022-05-19       Impact factor: 5.682

Review 2.  The Regulating Effect of Autophagy-Related MiRNAs in Kidney, Bladder, and Prostate Cancer.

Authors:  Kai Huang; Xiaoxin Sun; Haotian Wu; Jun Zhao; Yuli Jian; Zhongyang Xu; Shujing Wang; Deyong Yang
Journal:  J Oncol       Date:  2021-04-22       Impact factor: 4.375

Review 3.  MicroRNA as Potential Biomarkers of Platelet Function on Antiplatelet Therapy: A Review.

Authors:  Pamela Czajka; Alex Fitas; Daniel Jakubik; Ceren Eyileten; Aleksandra Gasecka; Zofia Wicik; Jolanta M Siller-Matula; Krzysztof J Filipiak; Marek Postula
Journal:  Front Physiol       Date:  2021-04-15       Impact factor: 4.566

4.  Altered Circulating MicroRNA Profiles After Endurance Training: A Cohort Study of Ultramarathon Runners.

Authors:  Ceren Eyileten; Zofia Wicik; Alex Fitas; Mikolaj Marszalek; Jenny E Simon; Salvatore De Rosa; Szczepan Wiecha; Jeffrey Palatini; Marek Postula; Lukasz A Malek
Journal:  Front Physiol       Date:  2022-01-25       Impact factor: 4.566

5.  Association Between the Expression of MicroRNA-125b and Survival in Patients With Acute Coronary Syndrome and Coronary Multivessel Disease.

Authors:  Gloria M Gager; Ceren Eyileten; Marek Postula; Aleksandra Gasecka; Joanna Jarosz-Popek; Georg Gelbenegger; Bernd Jilma; Irene Lang; Jolanta Siller-Matula
Journal:  Front Cardiovasc Med       Date:  2022-07-08

6.  Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19.

Authors:  Ceren Eyileten; Zofia Wicik; Sérgio N Simões; David C Martins-Jr; Krzysztof Klos; Wojciech Wlodarczyk; Alice Assinger; Dariusz Soldacki; Andrzej Chcialowski; Jolanta M Siller-Matula; Marek Postula
Journal:  RNA Biol       Date:  2022-01       Impact factor: 4.766

Review 7.  Flow-Responsive Noncoding RNAs in the Vascular System: Basic Mechanisms for the Clinician.

Authors:  Salvatore De Rosa; Claudio Iaconetti; Ceren Eyileten; Masakazu Yasuda; Michele Albanese; Alberto Polimeni; Jolanda Sabatino; Sabato Sorrentino; Marek Postula; Ciro Indolfi
Journal:  J Clin Med       Date:  2022-01-17       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.